Stig Egil Bojesen

Stig Egil Bojesen

Clinical Professor

Member of:

  • Clinical Biochemistry


  1. Published

    Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci

    Dai, J., Li, Z., Amos, C. I., Hung, R. J., Tardon, A., Andrew, A. S., Chen, C., Christiani, D. C., Albanes, D., van der Heijden, E. H. F. M., Duell, E. J., Rennert, G., Mckay, J. D., Yuan, J-M., Field, J. K., Manjer, J., Grankvist, K., Le Marchand, L., Teare, M. D., Schabath, M. B. & 17 others, Aldrich, M. C., Tsao, M., Lazarus, P., Lam, S., Bojesen, Stig Egil, Arnold, S., Wu, X., Haugen, A., Janout, V., Johansson, M., Brhane, Y., Fernandez-Somoano, A., Kiemeney, L. A., Davies, M. P. A., Zienolddiny, S., Hu, Z. & Shen, H., Mar 2019, In: Carcinogenesis. 40, 3, p. 432-440 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

    ABCTB Investigators, A. I., GEMO Study Collaborators, G. S. C. & kConFab, K., 2019, In: npj Breast Cancer. 5, 1, 14 p., 38.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Two truncating variants in FANCC and breast cancer risk

    ABCTB Investigators, A. I. & NBCS Collaborators, N. C., 2019, In: Scientific Reports. 9, 1, 14 p., 12524.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 919364